Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) EBIT Margin (2016 - 2025)

Historic EBIT Margin for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to 539.52%.

  • ProPhase Labs' EBIT Margin fell 819000.0% to 539.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 582.32%, marking a year-over-year decrease of 58857700.0%. This contributed to the annual value of 568.07% for FY2024, which is 5074400.0% down from last year.
  • As of Q3 2025, ProPhase Labs' EBIT Margin stood at 539.52%, which was down 819000.0% from 312.27% recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' EBIT Margin ranged from a high of 186.22% in Q4 2023 and a low of 1134.51% during Q4 2024
  • For the 5-year period, ProPhase Labs' EBIT Margin averaged around 178.28%, with its median value being 35.24% (2023).
  • As far as peak fluctuations go, ProPhase Labs' EBIT Margin skyrocketed by 2095400bps in 2023, and later tumbled by -13207300bps in 2024.
  • Quarter analysis of 5 years shows ProPhase Labs' EBIT Margin stood at 30.29% in 2021, then plummeted by -177bps to 23.32% in 2022, then soared by 898bps to 186.22% in 2023, then plummeted by -709bps to 1134.51% in 2024, then surged by 52bps to 539.52% in 2025.
  • Its EBIT Margin stands at 539.52% for Q3 2025, versus 312.27% for Q2 2025 and 255.97% for Q1 2025.